Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

被引：0

作者：

Maria Giovanna Quaranta

Luigina Ferrigno

Monica Monti

Roberto Filomia

Elisa Biliotti

Andrea Iannone

Guglielmo Migliorino

Barbara Coco

Filomena Morisco

Maria Vinci

Roberta D’Ambrosio

Liliana Chemello

Marco Massari

Donatella Ieluzzi

Francesco Paolo Russo

Pierluigi Blanc

Gabriella Verucchi

Massimo Puoti

Maria Grazia Rumi

Francesco Barbaro

Teresa Antonia Santantonio

Alessandro Federico

Luchino Chessa

Ivan Gentile

Massimo Zuin

Giustino Parruti

Giulia Morsica

Loreta A. Kondili

机构：

[1] Istituto Superiore di Sanità,Center for Global Health

[2] University of Florence,Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine

[3] University Hospital of Messina,Division of Clinical and Molecular Hepatology

[4] Policlinico Umberto I,Department of Clinical Medicine

[5] Sapienza University of Rome,Department of Emergency and Organ Transplantation, Gastroenterology Unit

[6] University of Bari,Division of Infectious Diseases

[7] San Gerardo Hospital,Hepatology and Liver Physiopathology Laboratory and Internal Medicine, Department of Clinical and Experimental Medicine

[8] University Hospital of Pisa,Gastroenterology and Hepatology Unit

[9] Federico II University Hospital,Department of Hepatology and Gastroenterology

[10] Niguarda Hospital,Gastroenterology and Hepatology Unit

[11] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Department of Medicine

[12] University Hospital of Padua,USD Liver Unit

[13] Infectious Diseases,Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology

[14] Azienda Unità Sanitaria Locale,Infectious Disease Unit

[15] IRCCS di Reggio Emilia,Department of Medical and Surgical Sciences, Infectious Disease Unit

[16] University Hospital of Verona,Department of Infectious Disease

[17] University of Padua,Hepatology Unit, San Giuseppe Hospital

[18] Santa Maria Annunziata Hospital,Infectious and Tropical Diseases Unit

[19] University Hospital S.Orsola-Malpighi,Infectious Diseases

[20] Niguarda Hospital,Department of Hepato

[21] University of Milan,Gastroenterology

[22] Azienda Ospedaliera di Padova,Liver Unit

[23] Ospedali Riuniti,Infectious Disease Unit

[24] University of Campania “Luigi Vanvitelli”,Gastroenterology and Hepatology Unit, San Paolo Hospital

[25] University Hospital,Infectious Disease Unit

[26] Federico II University Hospital,Department of Infectious Diseases

[27] University of Milan,undefined

[28] Spirito Santo General Hospital,undefined

[29] San Raffaele Hospital,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Hepatitis C virus; Human immunodeficiency virus; Coinfection; Real-life cohort; Direct-acting antivirals; Advanced liver disease; Sustained virological response; Clinical outcomes; Cirrhosis; Hepatocellular carcinoma; Viral eradication;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：362 / 372

页数：10

共 196 条

[1]

Platt L(2016)Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis Lancet Infect Dis. 16 797-808

[2]

Easterbrook P(2013)Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy Clin Infect Dis 57 1401-1408

[3]

Gower E(2013)Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain Clin Infect Dis 56 143-150

[4]

McDonald B(2016)Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras Clin Infect Dis 63 1160-1167

[5]

Sabin K(2014)Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection N Engl J Med 370 211-221

[6]

McGowan C(2014)Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection N Engl J Med 370 1483-1493

[7]

Yanny I(2019)Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Lancet 393 1453-1464

[8]

Macías J(2019)Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort) Hepatol Int. 13 66-74

[9]

Márquez M(2018)Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Gastroenterology 155 411-421

[10]

Téllez F(2016)Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts J Hepatol. 65 734-740

← 1 2 3 4 5 6 7 8 9 10 →